Investor Presentation - Q3 FY2023 Dear Sir/Madam, We are enclosing herewith our Company's Investor Presentation for Q3 FY2023. Kindly take the same on record. Thanking you,

pdf

Anuh Pharma Ltd.

09 Aug 2022

207.70

-0.57%

Investor Presentation

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

We are enclosing herewith our Company's Investor Presentation for Q1 FY2023.

pdf

Anuh Pharma Ltd.

31 May 2022

207.70

-0.57%

Earnings Call

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find attached herewith the Transcript of Earnings Audio Conference Call held on Monday, 30th May, 2022 at 4.30 PM wherein Financial Performance for Quarter and year ended 31st March, 2022 was discussed.

pdf

Anuh Pharma Ltd.

30 May 2022

207.70

-0.57%

Earnings Call

ANUH PHARMA LTD. - 506260 - Audio Recording Of The Earnings Conference Call

BSE India

Pursuant to Regulations 30 and 46(2)(ao) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to the subject cited, please note that the audio recording of the Q4 FY 2022.

pdf

Anuh Pharma Ltd.

30 May 2022

207.70

-0.57%

Earnings Call

ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Please find attached herewith the Outcome of Earnings Audio Conference Call held on Monday, 30th May, 2022 at 4.30 PM wherein Financial Performance for Quarter and year ended 31st March, 2022 was discussed.

pdf

Is Anuh Pharma Ltd. worth buying?

227 Votes:

Buy 72.69%

Sell 11.01%

Hold 16.3%